A new therapeutic ap-proach for treating of bisphosphonate associ-ated osteonecrosis of the jaws (BP-ONJ)
The administration of bisphosphonates is always necessary if a disease with high levels of bone resorption is given. Osteone-crosis of the jaws can arise as a contraindi-cation. This clinical picture is explained by a reduced bone turnover caused by bisphos-phonates. To date it has not been possible to develop specific therapies. The accom-plished symptomatic treatment is currently limited to antibiotic administration, mouth-washes and in the worst case operational removal of the necrotic tissue.
It was now possible to demonstrate that the administration of an agent, which is already available, can raise the viability of os-teoblasts significantly. So the agent enables to work against the osteonecrosis in an early state.
Further Information: PDF
IMG Innovations-Management GmbH
Phone: +49 (0)631/31668-50
Contact
Dr. Klaus Kobek
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Silicon Carbide Innovation Alliance to drive industrial-scale semiconductor work
Known for its ability to withstand extreme environments and high voltages, silicon carbide (SiC) is a semiconducting material made up of silicon and carbon atoms arranged into crystals that is…
New SPECT/CT technique shows impressive biomarker identification
…offers increased access for prostate cancer patients. A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more…
How 3D printers can give robots a soft touch
Soft skin coverings and touch sensors have emerged as a promising feature for robots that are both safer and more intuitive for human interaction, but they are expensive and difficult…
